| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.21 | 8e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |